What are the implications of retrospectively applying the 2017 McDonald MS diagnostic criteria to patients with CIS?
ECTRIMS Online Library, Gavin Giovannoni, 228497
Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis
ECTRIMS Online Library, Mauricio F. Farez, 228498
Diffusion tensor imaging in pediatric onset multiple sclerosis: differential links to information processing speed and memory functioning
ECTRIMS Online Library, Michael Shaw, 228513
Memory and identification of emotional expression in pediatric-onset multiple sclerosis
ECTRIMS Online Library, Tracy Lauren Fabri, 228514
Higher serum uric acid levels associated with smoking cessation but not disability or disease severity in patient with multiple sclerosis
ECTRIMS Online Library, Mohammed Alrouji, 228529
Demographics, lifestyle risk factors, and health outcomes of two large international samples of people with multiple sclerosis: HOLISM Longitudinal and Validation cohorts
ECTRIMS Online Library, Steve Simpson, Jr., 228530
Acceptability in clinical practice of MSCopilot, a smartphone application for the digital self-assessment of patients living with MS
ECTRIMS Online Library, Elisabeth Maillart, 228545
Motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
ECTRIMS Online Library, Noah Ayadi, 228546
Connectivity patterns within the visual network following damage to the optic nerve
ECTRIMS Online Library, Netta Levin, 228561
Vision and vision-related measures in progressive multiple sclerosis
ECTRIMS Online Library, Netta Levin, 228562
Analysis of neuronal morphology in the multiple sclerosis brain by diolistic labeling
ECTRIMS Online Library, Jordon Dunham, 228577
Thalamic lesion load does not relate to cortical lesion pathology: findings from a large cross-sectional multiple sclerosis cohort imaged at 7 Tesla
ECTRIMS Online Library, Ambica Mehndiratta, 228578
Multiple sclerosis susceptibility variants influence natural killer cell function and phenotype
ECTRIMS Online Library, Laura Ferrè, 228593
MS risk loci are not associated with adult-onset post-infectious acquired demyelinating syndromes (ADS)
ECTRIMS Online Library, Filippo Martinelli Boneschi, 228594
Analysis of CD4+ cells reveal increased exposure of multiple sclerosis patients to Clostridium perfringens epsilon toxin
ECTRIMS Online Library, Jennifer Linden, 228609
High levels of Epstein Barr virus capsid antigen (EBV VCA) IgG and nuclear antigen (EBNA-1) IgG are associated with multiple sclerosis disease activity
ECTRIMS Online Library, Cris Constantinescu, 228610
Modelling MS progression in the afferent visual system: retinal, optic radiation and visual cortex changes after clinically isolated optic neuritis
ECTRIMS Online Library, Joseph Kuchling, 228625
Multiple sclerosis susceptibility variants modulate lymphocytes effect on myelin repair
ECTRIMS Online Library, Pauline Buissonnière, 228626
Dynamics of pseudo-atrophy in relapsing-remitting MS patients treated with interferon beta-1a as assessed by monthly brain MRI
ECTRIMS Online Library, Marco Battaglini, 228641
Impact of repetitive transcranial magnetic stimulation on fractional anisotropy of left prefrontral cortex in relapsing remitting multiple sclerosis patients with depression
ECTRIMS Online Library, Nevin Shalaby, 228642
Predicting grey matter atrophy patterns in multiple sclerosis using T2-hyperintense lesion maps and connectome data
ECTRIMS Online Library, Matthias Bussas, 228657
The “central vein sign” in patients with diagnostic “red flags“ for multiple sclerosis: a prospective multicenter 3T study
ECTRIMS Online Library, Pietro Maggi, 228658
Optical coherence tomography measures and their relationship with grey matter networks in multiple sclerosis patients
ECTRIMS Online Library, Àngela Vidal-Jordana, 228673
Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging
ECTRIMS Online Library, Caspar Seitz, 228674
A game-changer for treating cognitive impairment in MS? Feasibility and preliminary efficacy of an in-home, unsupervised videogame-based digital therapeutic
ECTRIMS Online Library, Riley Bove, 228687
Face-to-face and telematics cognitive stimulation in multiple sclerosis patients
ECTRIMS Online Library, Marta Cerezo-García, 228688
Evolution of vestibular system involvement in patients with clinically isolated syndrome over two-year follow-up
ECTRIMS Online Library, Barbara Barun, 228690
Temporal changes of inflammation and endothelial dysfunction in multiple sclerosis related to the evolution of enhancing lesions on frequent MRI
ECTRIMS Online Library, Zsolt Illes, 228704
Transcriptomic effect of fingolimod on B cell differentiation and survival in multiple sclerosis patients and the relationship with NEDA response. Not everything is explained by lymphocyte retention
ECTRIMS Online Library, Irene Moreno Torres, 228705
Identification of a novel subgroup of relapsing-remitting multiple sclerosis patients with elevated peripheral blood antibody-secreting cells
ECTRIMS Online Library, Krista D. Disano, 228706
Recurring symptoms at the end of the natalizumab cycle: can we explain the wearing-off effect?
ECTRIMS Online Library, Zoé L.E. van Kempen, 228720
Immunomodulation associated with clinical and MRI worsening in patients with progressive MS treated with MD1003 (high dose pharmaceutical grade biotin)
ECTRIMS Online Library, Beatrice Pignolet, 228721
Dimethyl fumarate reduces the frequency of antigen-primed T cells and the potential of CNS transmigration in patients with multiple sclerosis
ECTRIMS Online Library, Rikke H. Hansen, 228722
Blood transcriptome analysis of alemtuzumab-treated MS patients from the CARE-MS I and II studies
ECTRIMS Online Library, Mindy Zhang, 228736
Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY extension
ECTRIMS Online Library, Gavin Giovannoni, 228737
Two-year assessment of No Evidence of Disease Activity (NEDA-3) and disability regression in patients with aggressive multiple sclerosis treated with alemtuzumab
ECTRIMS Online Library, Luca Prosperini, 228738
7-year outcomes in MS patients of African descent treated with alemtuzumab: follow-up of CARE-MS I and II (TOPAZ Study)
ECTRIMS Online Library, Mitzi Williams, 228752
Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial
ECTRIMS Online Library, Jerry Wolinsky, 228753
Longer-term safety with Siponimod treatment in multiple sclerosis: pooled analysis of data from the BOLD and EXPAND trials and their extensions
ECTRIMS Online Library, Ludwig Kappos, 228754
Infection risks among Swedish multiple sclerosis patients treated with rituximab compared to natalizumab, fingolimod, and injectable therapies: a nationwide cohort study
ECTRIMS Online Library, Thomas Frisell, 228768
Sex differences in the pivotal MS clinical trials: what is the evidence?
ECTRIMS Online Library, Riley Bove, 228769
Improvements in multiple domains of quality of life with alemtuzumab as assessed by the functional assessment of multiple sclerosis questionnaire over 6 years regardless of presence of thyroid adverse events
ECTRIMS Online Library, Aaron Boster, 228770
Relationship between overall response score of disability in MS with patient-reported outcome SF-36
ECTRIMS Online Library, Ih Chang, 228785
Patient-reported SymptoMScreen baseline scores in patients with relapsing-remitting multiple sclerosis enrolled in Phase IIIb studies of ocrelizumab (ENSEMBLE and CASTING)
ECTRIMS Online Library, Ilya Kister, 228786
Increased blood levels of high density lipoprotein (HDL) in patients with multiple sclerosis treated with fingolimod or dimethyl fumarate - a beneficial side effect and /or a potential biomarker?
ECTRIMS Online Library, Elsebeth Staun-Ram, 228787
Therapeutic inertia in multiple sclerosis care: a comparative study between Spain and Chile
ECTRIMS Online Library, Gustavo Saposnik, 228802
Normalization of butyrate-producing Faecalibacterium after 12 weeks intervention with delayed-release dimethyl fumarate in multiple sclerosis
ECTRIMS Online Library, Trygve Holmøy, 228803
Tolerability and safety of Dimethyl fumarate in relapsing multiple sclerosis: a prospective observational post-marketing study
ECTRIMS Online Library, Sarai Urtiaga, 228804
Welcome and introduction
ECTRIMS Online Library, Hans-Peter Hartung, 231860
Treating disease activity earlier: Evidence for long-term benefits
ECTRIMS Online Library, Mar Tintore, 231861
Ocrelizumab: From clinical trial data to longer-term outcomes
ECTRIMS Online Library, Andrew Chan, 231862
Clinical perspectives: Putting early, effective treatment into clinical practice
ECTRIMS Online Library, Rob Bermel, 231863
ECTRIMS Online Library, Session Speakers, 231864
Committing to generations, impacting patients: advancing disease management across the continuum of MS
ECTRIMS Online Library, Session Speakers, 234393
Treatment of PML and other opportunistic infections
ECTRIMS Online Library, Joseph Berger, 231829
Mortality rates in large US and Swedish rituximab-treated multiple sclerosis cohorts
ECTRIMS Online Library, Annette Langer-Gould, 231830
Cancer risk among Swedish multiple sclerosis patients: a nationwide cohort study comparing rituximab, fingolimod and natalizumab
ECTRIMS Online Library, Peter Alping, 231831
Severe encephalitis and meningoencephalitis with systemic symptoms after daclizumab therapy for multiple sclerosis
ECTRIMS Online Library, Imke Metz, 231832
Monitoring CNS inflammatory activity in natalizumab related PML with TSPO-PET
ECTRIMS Online Library, Christoph Mahler, 231833
ECTRIMS Online Library, Emmanuelle Waubant, 231834
ECTRIMS Online Library, Jiwon Oh, 231836
Potential of exercise and cognitive training
ECTRIMS Online Library, Iris-Katharina Penner, 231837
Cognitive rehabilitation and neuroimaging
ECTRIMS Online Library, John DeLuca, 231838
Damage to long-range connections is especially relevant for cognitive impairment in multiple sclerosis
ECTRIMS Online Library, Kim A Meijer, 231839
Early focal inflammatory disease is associated with long-term cognitive performance in relapse-onset multiple sclerosis
ECTRIMS Online Library, Wallace Brownlee, 231840
Cognitive processing speed assessment in clinical practice: clinical, patient reported outcome, and quantitative MRI correlations
ECTRIMS Online Library, K. Nakamuk, 231841
The effect of depression and bipolar disorder on multiple sclerosis disability worsening
ECTRIMS Online Library, Stefanie Binzer, 231842
Immunological phenotyping identifies MS patients with accentuated immune cell activation upon anti-CD20 treatment
ECTRIMS Online Library, Silke Häusser-Kinzel, 231843
Cladribine personalised dosing in people with MS (n>200) - four years experience in clinical care
ECTRIMS Online Library, Stefania De Trane, 231844
Importance of CD4+CCR5+ effector memory cells for immune surveillance
ECTRIMS Online Library, Sebastian Herich, 231845
Aquaporin-4-IgG seropositivity is associated with worse visual outcomes after optic neuritis, independent of inner retinal layer thinning and microcystic macular pathology
ECTRIMS Online Library, Elias S. Sotirchos, 231846
Vitreous haze as a novel marker for neurodegeneration in MS possibly indicating impairment of the retinal glymphatic system
ECTRIMS Online Library, Danko Coric, 231847
A nurse-led research to improve the tolerability of alemtuzumab by reducing peri-infusional reactions
ECTRIMS Online Library, Clara Maria Oriol, 231850
NMOSD and related autoantibody CNS disorders
ECTRIMS Online Library, Aksel Siva, 231851
Atypical inflammatory syndromes of the CNS
ECTRIMS Online Library, Mark Keegan, 231852
Primary and secondary inflammatory vasculopathies and other inflammatory disorders of the CNS mimicking MS
ECTRIMS Online Library, Claire Rice, 231853
General considerations in biomarker research and application
ECTRIMS Online Library, Bernhard Hemmer, 231854
Serum and CSF biomarkers in MS
ECTRIMS Online Library, Manuel Comabella, 231855
Basics of MS genetics
ECTRIMS Online Library, Sergio E. Baranzini, 231856
What have we learnt on remyelination in MS? an historical perspective
ECTRIMS Online Library, Catherine Lubetzki, 231857
Promoting exogenous remyelination: from basic sciences to translation
ECTRIMS Online Library, Steven Goldman, 231858
Promoting endogenous remyelination: from basic sciences to translation
ECTRIMS Online Library, Ari Green, 231859
What should be imaged in progressive MS: the lesson from pathology
ECTRIMS Online Library, Hans Lassmann, 231817
Understanding progression: a PET imaging perspective
ECTRIMS Online Library, Bruno Stankoff, 231819
Cytoskeletal breakdown during axon injury in a mouse model of neuromyelitis optica
ECTRIMS Online Library, Marina Herwerth, 231820
Mucosal addressin cell adhesion molecule 1 mediated intestinal lymphocyte homing is critical for the development of experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Kristina Kuhbandner, 231821
Vitamin D augments glucocorticosteroid efficacy via inhibition of mTORc1
ECTRIMS Online Library, Maud Bagnoud, 231822
A novel β1-integrin/KV1.3 -mediated vesicular glutamate release pathway in Th17 cells
ECTRIMS Online Library, Katharina Birkner, 231823
The oligodendroglial differentiation block in multiple sclerosis- mediated by intrinsic or extrinsic factors?
ECTRIMS Online Library, Laura Starost, 231824
Digital solutions that support MS nursing care
ECTRIMS Online Library, Rachel Morrison, 231825
Adolescent transition - lessons from two specialist centres
ECTRIMS Online Library, Katie Hanson, 231826
Digital care programme NeuroResponse
ECTRIMS Online Library, Bernadette Porter, 231827
Efficacy in the real world
ECTRIMS Online Library, Tomas Kalincik, 231796
Traps and pitfalls (methodological issues)
ECTRIMS Online Library, Maria Pia Sormani, 231797
Multiple sclerosis in Germany 2018 - update on baseline data from the German MS Registry
ECTRIMS Online Library, Peter Flachenecker, 231798
Determinants of disability accumulation in secondary-progressive multiple sclerosis
ECTRIMS Online Library, Nathaniel Lizak, 231799
Neuropathological injury in MS and relationship to structural MRI metrics
ECTRIMS Online Library, Jeroen Geurts, 231811
Functional MRI studies in MS: update on brain plasticity and repair
ECTRIMS Online Library, Christian Enzinger, 231812
Functional relevance of MRI in early MS, correlation with cognitive performance and related outcomes
ECTRIMS Online Library, Bruno Brochet, 231813
Unraveling the cause of neuronal mitochondrial dysfunction in MS
ECTRIMS Online Library, Don Mahad, 231814

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings